Associated anomalies in Pierre Robin sequence.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
09 2023
Historique:
revised: 08 06 2023
received: 10 01 2023
accepted: 22 06 2023
medline: 21 8 2023
pubmed: 21 7 2023
entrez: 21 7 2023
Statut: ppublish

Résumé

Pierre Robin sequence (PRS) is frequently co-occurring with other non-PRS congenital anomalies. The types and the prevalence of anomalies co-occurring with PRS vary in the reported studies. The aims of this report was to study the types and the prevalence of the anomalies co-occurring with PRS in a well-studied population northeastern France. The types and the prevalence of anomalies co-occurring in cases with PRS were ascertained in all terminations of pregnancy, stillbirths and live births in 387,067 births occurring consecutively during the period 1979-2007 in the area covered by our registry of congenital anomalies which is population-based, 89 cases of PRS were registered during the study period with a prevalence of 2.29 per 10,000 births, 69.7% of the cases had associated non-PRS anomalies. Chromosomal abnormalities were present in 10 (11.2%) cases including three 22 q11.2 deletion. Non-chromosomal recognizable conditions were diagnosed in 27 cases (30.3%) including 10 Stickler syndrome, 8 Treacher Collins syndrome, 3 cases with short stature and 6 other syndromes. Multiple congenital anomalies (MCA) were present in 25 cases (28.1%). The most frequent MCA were in the ear, face and neck (35 out of 98 anomalies, 35.7%), cardiovascular (18 anomalies, 18.4%), musculoskeletal (11 anomalies, 11.2%), central nervous (7 anomalies, 7.1%), urinary (6 anomalies, 6.1%), and eye (6 anomalies, 6.1%) system. The high prevalence of associated anomalies justifies a thorough screening for other congenital anomalies in cases with PRS.

Identifiants

pubmed: 37477275
doi: 10.1002/ajmg.a.63344
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2312-2323

Informations de copyright

© 2023 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Basart, H., Paes, E. C., Maas, S. M., Boogaard, M. H. D., Hagen, J. M., Breugem, C. C., & Hennekam, R. C. (2015). Etiology and pathogenesis of robin sequence in a large Dutch cohort. American Journal of Medical Genetic. Part A, 167A(9), 1983-1992.
Breugem, C. C., & Courtemanche, D. J. (2010). Robin sequence: Clearing nosologic confusion. Cleft Palate Craniofacial Journal, 47, 197-200.
Bush, A., & Williams, P. G. (1983). Incidence of the Robin anomalad (Pierre Robin Syndrome). British Journal of Plastic Surgery, 36, 434-437.
Butow, K. W., Hoogendijk, C. F., & Zwahlen, R. A. (2009). Pierre Robin sequence: Appearances and 25 years of experience with an innovative treatment protocol. Journal of Pediatric Surgery, 44, 2112-2118.
Caouette-Laberge, L., Bayet, B., & Larocque, Y. (1994). The Pierre Robin sequence: Reviewof 125 cases and evolution of treatment modalities. Plastic and Reconstructive Surgery, 93, 934-942.
Cleary, B., Loane, M., Addor, M.-C., Barisic, I., de Walle, H. E. K., Dias, C. M., & Neville, A. (2020). Methadone, Pierre Robin sequence and other congenital anomalies. Archives of Disease in Childhood-Fetal and Neonatal Edition, 105(2), 151-157.
Cohen, M. M. (1999). Robin sequences and complexes: Causal heterogeneity and pathogenetic/phenotypic variability. American Journal of Medical Genetics, 4, 311-315.
Costa, M. A., Tu, M. M., Murage, K. P., Tholpady, S. S., Engle, W. A., & Flores, R. L. (2014). Robin sequence: Mortality, causes of death, and clinical outcomes. Plastic and Reconstructive Surgery, 134, 738-745.
Evans, A. K., Rahbar, R., Rogers, G. F., Mulliken, J. B., & Volk, M. S. (2006). Robin sequence: A retrospective review of 115 patients. International Journal of Pediatric Otorhinolaryngology, 70, 973-980.
Filip, C., Billaud Feragen, K., Skartveit Lemvik, J., Lindberg, N., Andersson, E. M., & Høgevold HE, R. M. (2015). Multidisciplinary aspects of 104 patients with Pierre Robin sequence. The Cleft Palate-Craniofacial Journal, 52(6), 732-742.
Flores, R. L., Greathouse, S. T., Costa, M., Tahiri, Y., Soleimani, T., & Tholpady, S. S. (2015). Defining failure and its predictors in mandibular distraction for Robin sequence. Journal of Cranio-Maxillo-Facial Surgery, 43(8), 1614-1619.
Flores, R. L., Tholpady, S. S., Sati, S., Fairbanks, G., Socas, J., Choi, M., & Havlik, R. J. (2014). The surgical correction of Pierre Robin sequence: Mandibular distraction osteogenesis versus tongue-lip adhesion. Plastic and Reconstructive Surgery, 6, 1433-1439.
Glynn, F., Fitzgerald, D., Earley, M. J., & Rowley, H. (2011). Pierre Robin sequence: An institutional experience in the multidisciplinary management of airway, feeding and serous otitis media challenges. International Journal of Pediatric Otorhinolaryngology, 75(9), 1152-1155.
Gomez-Ospina, N., & Bernstein, J. A. (2016). Clinical, cytogenetic, and molecular outcomes in a series of 66 patients with Pierre Robin sequence and literature review: 22q11.2 deletion is less common than other chromosomal anomalies. American Journal of Medical Genetic. Part A, 170A, 870-880.
Hanson, J. W., & Smith, D. W. (1975). U-shaped palatal defect in the Pierre Robin anomalad: Developmental and clinical relevance. Journal of Pediatrics, 87, 30-33.
Hennekam, R. C., Biesecker, L. G., Allanson, J. E., Hall, J. G., Opitz, J. M., Temple, I. K., & Carey, J. C. (2013). Elements of morphology: General terms for congenital anomalies. American Journal of Medical Genetics. Part A, 161A, 2726-2733.
Holder-Espinasse, M., Abadie, V., Cormier-Daire, V., Beyler, C., Manach, Y., Munnich, A., & Amiel, J. (2001). Pierre Robin sequence: A series of 117 consecutive cases. Journal of Pediatrics, 139, 588-590.
Honein, M. A., Rasmussen, S. A., Reefhuis, J., Romitti, P. A., Lammer, E. J., Sun, L., & Correa, A. (2007). Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology, 18, 226-233.
Hsieh, Y. Y., Chang, C. C., Tsai, H. D., Yang, T. C., Lee, C. C., & Tsai, C. H. (1999). The prenatal diagnosis of Pierre-Robin sequence. Prenatal Diagnosis, 19, 567-569.
Izumi, K., Konczal, L. L., Mitchell, A. L., & Jones, M. C. (2012). Underlying genetic diagnosis of Pierre Robin sequence: Retrospective chart review at two children's hospitals and a systematic literature review. Journal of Pediatrics, 160(645-650), e642.
Junaid, M., Slack-Smith, L., Wong, K., Bourke, J., Baynam, G., Calache, H., & Leonard, H. (2022). Epidemiology of rare craniofacial anomalies: Retrospective Western Australian population data linkage study. Journal of Pediatrics, 241(162-172), e9.
Kallen, B., Harris, J., & Robert, E. (1996). The epidemiology of orofacial clefts 2. Associated malformations. Journal of Craniofacial Genetics and Developmental Biology, 16(4), 242-248.
Lary, J. M., & Paulozzi, L. J. (2001). Sex differences in the prevalence of human birth defects: A population-based study. Teratology, 64, 237-251.
Logjes, R. J. H., Breugem, C. C., Van Haaften, G., Paes, E. C., Sperber, G. H., van den Boogaard, M.-J. H., & Farlie, P. G. (2018). The ontogeny of Robin sequence. American Journal of Medical Genetics, Part A, 176A, 1349-1368.
Lowry, R. B., Bedard, T., Sibbald, B., Harder, J. R., Trevenen, C., Horobec, V., & Dyck, J. D. (2013). Congenital heart defects and major structural noncardiac anomalies in Alberta, Canada, 1995-2002. Birth Defects Research (Part A) Clinical and Molecular Teratolology, 97(2), 79-86.
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., & Ledbetter, D. H. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 86(5), 749-764.
Paes, E. C., van Nunen, D. P., Basart, H., Don Griot, J. P., van Hagen, J. M., van der Horst, C., & Breugem, C. C. (2015). Birth prevalence of Robin sequence in The Netherlands from 2000-2010: A retrospective population-based study in a large Dutch cohort and review of the literature. American Journal of Medical Genetics Part A, 167 A, 1972-1982.
Printzlau, A., & Andersen, M. (2004). Pierre Robin sequence in Denmark: Aretrospective population-based epidemiological study. Cleft Palate Craniofacial Journal, 41, 47-52.
Queißer-Luft, A., & Spranger, J. (2006). Congenital malformations. Deutsches Ärzteblatt, 103A, 2464-2471.
Rasmussen, S. A., Olney, R. S., Holmes, L. B., Lin, A. E., Keppler-Noreuil, K. M., Moore, C. A., & National Birth Defects Prevention Study. (2003). Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Research (Part A) Clinical and Molecular Teratology, 67(3), 193-201.
Santoro, M., Coi, A., Barišić, I., Pierini, A., Addor, M. C., Baldacci, S., Ballardini, E., Boban, L., Braz, P., Cavero-Carbonell, C., de Walle, H. E. K., Draper, E. S., Gatt, M., Haeusler, M., Klungsøyr, K., Kurinczuk, J. J., Materna-Kiryluk, A., Lanzoni, M., Lelong, N., … Garne, E. (2021). Epidemiology of Pierre-Robin sequence in Europe: A population-based EUROCAT study. Paediatric Perinatology Epidemiology, 35(5), 530-539.
Scott, R. S., & Mader, S. M. (2014). Regional variations in the presentation and surgical management of Pierre Robin sequence. Laryngoscope, 124, 2818-2825.
Sheffield, L. J., Reiss, J. A., Strohm, K., & Gilding, M. (1987). A genetic followup study of 64 patients with the Pierre Robin complex. American Journal of Medical Genetics, 28, 25-36.
Shprintzen, R. J. (1988). Pierre Robin, micrognathia, and airway obstruction: The dependency of treatment on accurate diagnosis. International Anesthesiology Clinics, 26, 64-71.
Shprintzen, R. J. (1992). The implications of the diagnosis of Robin sequence. Cleft Palate Craniofacial Journal, 29, 205-209.
Stoll, C. (1985). The northeastern France birth defects monitoring system. Progress in Clinical Research, 163B, 157-162.
Stoll, C., Alembik, Y., Dott, B., & Roth, M.-P. (2010). Associated malformations in patients with limb reduction deficiencies. European Journal of Medical Genetics, 53(5), 286-290.
Thouvenin, B., Djadi-Prat, J., Chalouhi, C., Pierrot, P., Lyonnet, S., Couly, G., & Abadie, V. (2013). Developmental outcome in Pierre Robin sequence: A longitudinal and prospective study of a consecutive series of severe phenotypes. American Journal of Medical Genetics, Part A, 161A(2), 312-319.
van den Elzen, A. P., Semmekrot, B. A., Bongers, E. M., Huygen, P. L., & Marres, H. A. (2001). Diagnosis and treatment of the Pierre Robin sequence: Results of a retrospective clinical study and review of the literature. European Journal of Pediatrics, 160, 47-53.
Vatlach, S., Maas, C., & Poets, C. F. (2014). Birth prevalence and initial treatment of Robin sequence in Germany: A prospective epidemiologic study. Orphanet Journal of Rare Disease, 9, 9-14.
Weaver, K. N., Sullivan, B. R., Balow, S. A., Hopkin, S., Chini, B. A., Pan, B. S., & Saal, H. M. (2022). Robin sequence without cleft palate: Genetic diagnoses and management implications. American Journal of Medical Genetics, Part A, 188A, 160-177. https://doi.org/10.1002/ajmg.a.62515
Williams, A. J., Williams, M. A., Walker, C. A., & Bush, P. G. (1981). The Robin anomalad (Pierre Robin syndrome) a follow up study. Archives of Disease in Childhood, 56(3), 663-668.
Wright, M., Mehendale, F., & Urquhart, D. S. (2018). Epidemiology of Robin sequence with cleft palate in the east of Scotland between 2004 and 2013. Pediatric Pulmonology, 53(8), 1040-1045.

Auteurs

Claude Stoll (C)

Laboratoire de Génétique Médicale, Faculté de Médecine, Strasbourg, France.

Y Alembick (Y)

Laboratoire de Génétique Médicale, Faculté de Médecine, Strasbourg, France.

M P Roth (MP)

Laboratoire de Génétique Médicale, Faculté de Médecine, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH